Jes Olesen , MD, DMSc, DHonC

Jes Olesen , MD, DMSc, DHonC

Professor at the University of Copenhagen,

Co-chair of the Danish Headache Center, Department of Neurology, Glostrup Hospital in Copenhagen, Denmark.

Co-founder of the European Federation of Neurological Societies and of the European Brain Council

Past President of the International Headache Society and current Chairman of the Headache Classification Committee

 

Professor Olesen’s research interests are focused on migraine and other headaches and span from clinical studies and classification over human pathophysiological studies involving particularly brain blood flow and MR all the way to basic research into neural and vascular signaling mechanisms.

Back to List

About Colucid

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company's investors include Pappas Ventures, Domain Associates, Care Capital, Pearl Street Venture Funds and Triathlon Medical Ventures.

Learn More About CoLucid

Lasmiditan

image of lasmiditan structure

Lasmiditan is a member of a novel chemical class called "ditans." Lasmiditan penetrates the central nervous system (CNS) and selectively targets 5-HT1F receptors expressed in the trigeminal nerve pathway.

Learn More About Lasmiditan